South Korea to Speed Up Approval of Some Imported Over-the-Counter Products
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
- South Korea’s Ministry of Food and Drug Safety proposed easing documentation requirements for some imported quasi-drugs.
- Products made at overseas facilities that meet GMP standards would no longer require manufacturers to submit a manufacturing certificate.
- The ministry announced the proposed revision on Sept. 4 and will accept public comments through Sept. 23.
South Korea’s Ministry of Food and Drug Safety plans to reduce the paperwork companies must submit when seeking approval for some quasi-drugs. Products imported from overseas facilities that meet good manufacturing practice standards would be exempt from submitting a manufacturing certificate.
The ministry announced the proposed revision to its rules on quasi-drug product approval, notification and review on Sept. 4. It will accept public comments through Sept. 23.
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.